Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19928 | 26260755 | Gut Liver | Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population. | 2016 | Details |
| A19940 | 26252921 | J Pediatr Gastroenterol Nutr | Physical Activity Is Prospectively Associated With Adolescent Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A19950 | 26246323 | J Nutr | Citrulline and Nonessential Amino Acids Prevent Fructose-Induced Nonalcoholic Fatty Liver Disease in Rats. | 2015 | Details |
| A19951 | 26244718 | J Investig Med | Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology. | 2015 | Details |
| A19954 | 26242295 | Trials | The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial. | 2015 | Details |
| A19955 | 26242257 | Curr Med Chem | Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy. | 2015 | Details |
| A19956 | 26242131 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [The New Idea about Early Intervention for Type 2 Diabetes Based on Gan Disease Transferring to Pi in Metabolic Diseases]. | 2015 | Details |
| A19966 | 26235878 | Biochem Biophys Res Commun | The role of endoplasmic reticulum stress and insulin resistance in the occurrence of goose fatty liver. | 2015 | Details |
| A19968 | 26234526 | Br J Nutr | The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. | 2015 | Details |
| A19973 | 26232233 | Am J Physiol Heart Circ Physiol | Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. | 2015 | Details |
| A19978 | 26228676 | J Clin Lipidol | Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease. | 2015 | Details |
| A19981 | 26228038 | Lipids Health Dis | Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds. | 2015 | Details |
| A19987 | 26224399 | Expert Rev Gastroenterol Hepatol | Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. | 2015 | Details |
| A19997 | 26215532 | Am J Gastroenterol | Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy. | 2015 | Details |
| A19999 | 26215323 | BMC Gastroenterol | Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study. | 2015 | Details |
| A20000 | 26215259 | Nat Rev Endocrinol | Physiological and pathophysiological roles of NAMPT and NAD metabolism. | 2015 | Details |
| A20002 | 26215060 | Turk J Gastroenterol | Increased plasma CgA levels associated with nonalcoholic fatty liver disease. | 2015 | Details |
| A20004 | 26214582 | Lab Invest | Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. | 2015 | Details |
| A20016 | 26203576 | Rev Med Chil | [Second Consensus of the Chilean Society of Endocrinology and Diabetes about insulin resistance]. | 2015 | Details |
| A20017 | 26203166 | J Endocrinol | Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21. | 2015 | Details |
| A20018 | 26202818 | Aliment Pharmacol Ther | Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study. | 2015 | Details |
| A20022 | 26201937 | Clin Endocrinol (Oxf) | Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat. | 2015 | Details |
| A20023 | 26201461 | Drugs | Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway. | 2015 | Details |
| A20028 | 26200028 | Rev Esp Quimioter | Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients. | 2015 | Details |
| A20032 | 26198953 | Nan Fang Yi Ke Da Xue Xue Bao | [Association between polymorphisms in pigment epithelium-derived factor gene promoter region and non-alcoholic fatty liver disease in type 2 diabetes mellitus]. | 2015 | Details |
| A20033 | 26198758 | Hepatol Int | Effect of metformin treatment on circulating osteoprotegerin in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20034 | 26198708 | Wiley Interdiscip Rev RNA | 'Micro-managers' of hepatic lipid metabolism and NAFLD. | 2015 | Details |
| A20035 | 26197341 | Biomolecules | Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20043 | 26193757 | Int J Urol | Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review. | 2015 | Details |
| A20054 | 26189985 | Clin Res Hepatol Gastroenterol | Synergy between NAFLD and AFLD and potential biomarkers. | 2015 | Details |
| A20061 | 26185598 | World J Diabetes | Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. | 2015 | Details |
| A20062 | 26185381 | World J Gastroenterol | Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease. | 2015 | Details |
| A20063 | 26185377 | World J Gastroenterol | Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats. | 2015 | Details |
| A20073 | 26174847 | Sleep Breath | Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults. | 2015 | Details |
| A20083 | 26168700 | J Nutr Biochem | Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. | 2015 | Details |
| A20090 | 26166101 | Medicine (Baltimore) | Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20092 | 26160474 | Clin Res Hepatol Gastroenterol | Novel therapeutic targets for steatohepatitis. | 2015 | Details |
| A20100 | 26155043 | J Clin Exp Hepatol | The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20102 | 26154274 | Menopause | Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women. | 2015 | Details |
| A20106 | 26151226 | Clin Biochem | Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. | 2015 | Details |
| A20111 | 26148225 | Liver Int | I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease. | 2015 | Details |
| A20115 | 26147081 | Nature | The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. | 2015 | Details |
| A20122 | 26140084 | World J Hepatol | Systematic review: Preventive and therapeutic applications of metformin in liver disease. | 2015 | Details |
| A20124 | 26139990 | World J Gastroenterol | Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance. | 2015 | Details |
| A20133 | 26134926 | Expert Opin Drug Saf | Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect? | 2015 | Details |
| A20136 | 26133820 | Zhonghua Gan Zang Bing Za Zhi | [Effects of telmisartan on resistin expression in a rat model of nonalcoholic steatohepatitis and insulin resistance]. | 2015 | Details |
| A20137 | 26133486 | Int J Mol Med | Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model. | 2015 | Details |
| A20141 | 26132376 | Pediatr Obes | Non-Alcoholic Fatty Liver Disease (NAFLD) in children and adolescents with Prader-Willi Syndrome (PWS). | 2015 | Details |
| A20146 | 26124760 | Front Immunol | Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies. | 2015 | Details |
| A20148 | 26123841 | Liver Int | Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. | 2015 | Details |
| A20153 | 26120587 | Biomed Res Int | Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals. | 2015 | Details |
| A20168 | 26114083 | Curr Hepatol Rep | PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASE. | 2015 | Details |
| A20181 | 26102213 | Nutrients | Hepatic Steatosis as a Marker of Metabolic Dysfunction. | 2015 | Details |
| A20186 | 26098879 | PLoS One | Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet. | 2015 | Details |
| A20187 | 26097608 | Int J Clin Exp Pathol | Interactions of central obesity with rs3918242 on risk of non-alcoholic fat liver disease: a preliminary case-control study. | 2015 | Details |
| A20190 | 26094890 | Cell Metab | Jejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling. | 2015 | Details |
| A20191 | 26090879 | Int J Sports Med | Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver Disease. | 2015 | Details |
| A20193 | 26090470 | Biomed Res Int | How Inflammation Impinges on NAFLD: A Role for Kupffer Cells. | 2015 | Details |
| A20194 | 26090468 | Biomed Res Int | Gut Microbiota: Association with NAFLD and Metabolic Disturbances. | 2015 | Details |
| A20197 | 26090093 | J Nutr Sci | Assessment of cardiometabolic risk in children in population studies: underpinning developmental origins of health and disease mother-offspring cohort studies. | 2015 | Details |
| A20205 | 26085904 | World J Hepatol | Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics. | 2015 | Details |
| A20212 | 26080905 | Minerva Gastroenterol Dietol | The diagnosis and treatment of non-alcoholic fatty liver disease. | 2015 | Details |
| A20220 | 26078565 | World J Gastroenterol | Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. | 2015 | Details |
| A20229 | 26076562 | Rom J Intern Med | Noninvasive Markers of Improvement of Liver Steatosis Achieved by Weight Reduction in Patients with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20233 | 26073454 | Prog Lipid Res | Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. | 2015 | Details |
| A20246 | 26064858 | J Lifestyle Med | SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease. | 2014 | Details |
| A20254 | 26062078 | Eur J Gastroenterol Hepatol | Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20259 | 26058864 | Am J Physiol Endocrinol Metab | Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. | 2015 | Details |
| A20266 | 26055348 | Nutr Res | Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats. | 2015 | Details |
| A20268 | 26052390 | World J Hepatol | Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. | 2015 | Details |
| A20270 | 26052382 | World J Hepatol | Non-alcoholic fatty liver disease - the heart of the matter. | 2015 | Details |
| A20271 | 26052378 | World J Hepatol | Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. | 2015 | Details |
| A20272 | 26052375 | World J Hepatol | Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets. | 2015 | Details |
| A20276 | 26049707 | Eur J Gastroenterol Hepatol | Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test. | 2015 | Details |
| A20277 | 26049666 | Clin Investig Arterioscler | [Role of metabolic lipases and lipotoxicity in the development of non-alcoholic steatosis and non-alcoholic steatohepatitis]. | 2015 | Details |
| A20278 | 26049073 | Semin Thromb Hemost | Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20279 | 26047899 | Int J Biol Macromol | Protective effects of Ginkgo biloba leaf polysaccharide on nonalcoholic fatty liver disease and its mechanisms. | 2015 | Details |
| A20288 | 26045279 | Dig Dis | Use of farnesoid X receptor agonists to treat nonalcoholic fatty liver disease. | 2015 | Details |
| A20292 | 26042770 | PLoS One | mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC). | 2015 | Details |
| A20298 | 26040357 | Nutr Hosp | Predictive factors of non-alcoholic steatohepatitis: relationship with metabolic syndrome. | 2015 | Details |
| A20301 | 26039828 | Arq Gastroenterol | Nonalcoholic fatty liver disease in patients with coronary disease from a Brazil northeast area. | 2016 | Details |
| A20302 | 26039731 | PLoS One | Intravenous Mycobacterium Bovis Bacillus Calmette-Guérin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice. | 2015 | Details |
| A20305 | 26038701 | Pharmacol Res Perspect | Metformin protects primary rat hepatocytes against oxidative stress-induced apoptosis. | 2015 | Details |
| A20309 | 26035752 | Int J Mol Sci | Effect of Chronic Pioglitazone Treatment on Hepatic Gene Expression Profile in Obese C57BL/6J Mice. | 2015 | Details |
| A20312 | 26034364 | World J Gastroenterol | Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population. | 2015 | Details |
| A20313 | 26033743 | J Nutr Biochem | Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease. | 2015 | Details |
| A20316 | 26032587 | Pharmacol Res | Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial. | 2015 | Details |
| A20320 | 26031147 | Klin Med (Mosk) | [Metabolic disorder and polymorphism of the genes encoding for beta-2-adrenergic receptor and apolipoproteins B in chronic hepatitis C and non-alcoholic fatty liver diseases]. | 2015 | Details |
| A20335 | 26024975 | Endocrine | Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis? | 2015 | Details |
| A20337 | 26024397 | Rocz Panstw Zakl Hig | Health effects of changes in the structure of dietary macronutrients intake in western societies. | 2015 | Details |
| A20340 | 26021772 | Saudi J Gastroenterol | The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease. | 2016 | Details |
| A20345 | 26019740 | World J Hepatol | Valproic acid and nonalcoholic fatty liver disease: A possible association? | 2015 | Details |
| A20359 | 26017459 | Pediatr Blood Cancer | Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation. | 2015 | Details |
| A20360 | 26017330 | Mol Med Rep | Lycium ruthenicum extract alleviates high-fat diet-induced nonalcoholic fatty liver disease via enhancing the AMPK signaling pathway. | 2015 | Details |
| A20367 | 26011302 | Metab Syndr Relat Disord | Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20368 | 26011231 | Eur J Gastroenterol Hepatol | Increased abdominal fat levels measured by bioelectrical impedance are associated with histological lesions of nonalcoholic steatohepatitis. | 2015 | Details |
| A20370 | 26006114 | Gut | Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease. | 2015 | Details |
| A20373 | 26005676 | Hepatobiliary Surg Nutr | Fatty liver disease in diabetes mellitus. | 2015 | Details |
| A20375 | 26004139 | Exp Gerontol | Aging impairs the hepatic subcellular distribution of ChREBP in response to fasting/feeding in rats: Implications on hepatic steatosis. | 2015 | Details |
| A20377 | 26003827 | J Endocrinol Invest | Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link? | 2015 | Details |